AIMS: Although lead exposure has, in the absence of mathematical modelling, been believed to elevate blood pressure in females, it is necessary to clarify the relation between lead and blood pressure by eliminating confounding factors in the analysis. METHODS: Blood lead was measured in 193 female workers, including 123 lead exposed workers. Possible confounding factors were controlled by multiple regression analyses. RESULTS AND CONCLUSIONS: Blood lead above 40 micro g/dl was found to be the most potent factor for elevating systolic/diastolic blood pressure. Aging, urine protein, and plasma triglyceride also contributed to systolic/diastolic/pulse pressure increase, but hypertensive heredity did not. Data suggested that lead induced changes in lipoprotein metabolism may play an important role in the lead induced blood pressure increase in female workers.
AIMS: Although lead exposure has, in the absence of mathematical modelling, been believed to elevate blood pressure in females, it is necessary to clarify the relation between lead and blood pressure by eliminating confounding factors in the analysis. METHODS: Blood lead was measured in 193 female workers, including 123 lead exposed workers. Possible confounding factors were controlled by multiple regression analyses. RESULTS AND CONCLUSIONS: Blood lead above 40 micro g/dl was found to be the most potent factor for elevating systolic/diastolic blood pressure. Aging, urine protein, and plasma triglyceride also contributed to systolic/diastolic/pulse pressure increase, but hypertensive heredity did not. Data suggested that lead induced changes in lipoprotein metabolism may play an important role in the lead induced blood pressure increase in female workers.
Authors: R Ehrlich; T Robins; E Jordaan; S Miller; S Mbuli; P Selby; S Wynchank; A Cantrell; M De Broe; P D'Haese; A Todd; P Landrigan Journal: Occup Environ Med Date: 1998-07 Impact factor: 4.402
Authors: Ugur Nadir Karakulak; Sercan Okutucu; Utku Lokman; Ovunc Bilgin; Engin Tutkun; Omer Hinc Yilmaz; Ali Oto Journal: Acta Cardiol Sin Date: 2019-01 Impact factor: 2.672